Analyst Activity – Piper Jaffray Companies Initiates Coverage On Ultragenyx Pharmaceutical (NASDAQ:RARE) (NASDAQ:RARE) With a Overweight

ME Staff
-
0

Analyst Ratings For Ultragenyx Pharmaceutical (NASDAQ:RARE) (NASDAQ:RARE)

Today, Piper Jaffray Companies initiated coverage on Ultragenyx Pharmaceutical (NASDAQ:RARE) (NASDAQ:RARE) with a Overweight with a price target of $67.00.

Some recent analyst ratings include

  • 3/22/2018-Piper Jaffray Companies initiated coverage with a Overweight rating.
  • 2/23/2018-Robert W. Baird Reiterated Rating of Buy.
  • 2/21/2018-Morgan Stanley Reiterated Rating of Equal Weight .
  • 2/21/2018-JPMorgan Chase & Co. Reiterated Rating of Market Outperform .
  • 2/21/2018-Stifel Nicolaus Reiterated Rating of Buy .
  • 1/22/2018-Evercore ISI Upgrade from a “In-Line ” rating to a ” Outperform” rating.

Recent Insider Trading Activity For Ultragenyx Pharmaceutical (NASDAQ:RARE) (NASDAQ:RARE)
Ultragenyx Pharmaceutical (NASDAQ:RARE) (NASDAQ:RARE) has insider ownership of 9.20% and institutional ownership of 87.19%.

  • On 8/28/2017 Emil D Kakkis, CEO, bought 7,500 with an average share price of $52.52 per share and the total transaction amounting to $393,900.00.
  • On 5/26/2017 Theodore Alan Huizenga, VP, sold 480 with an average share price of $57.46 per share and the total transaction amounting to $27,580.80.
  • On 3/9/2017 Theodore Alan Huizenga, Insider, sold 2,500 with an average share price of $86.34 per share and the total transaction amounting to $215,850.00.
  • On 3/2/2017 Shalini Sharp, CFO, sold 12,000 with an average share price of $90.10 per share and the total transaction amounting to $1,081,200.00.
  • On 2/27/2017 Shalini Sharp, CFO, sold 12,000 with an average share price of $80.14 per share and the total transaction amounting to $961,680.00.
  • On 12/5/2016 William Aliski, Director, sold 6,000 with an average share price of $78.19 per share and the total transaction amounting to $469,140.00.
  • On 11/9/2016 Shalini Sharp, CFO, sold 24,000 with an average share price of $71.20 per share and the total transaction amounting to $1,708,800.00.

Recent Trading Activity for Ultragenyx Pharmaceutical (NASDAQ:RARE) (NASDAQ:RARE)
Shares of Ultragenyx Pharmaceutical (NASDAQ:RARE) closed the previous trading session at 52.60 up +0.26 0.51% with 121257 shares trading hands.